Business suspensions and delivery delays caused by COVID-19 and other infectious diseases
First written in FY2023. 4 of 6 entries say "Restated". Latest entry: FY2026-H1.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2026-H1RestatedAnnual report
「During the interim consolidated accounting period, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
It has been confirmed that there have been no material changes regarding the risk of business suspension and delivery delays due to infectious diseases and other conditions. - FY2025ReframedAnnual reportThe risk of business suspension and delivery delays from infectious diseases alone is not presented as a separate item, but has been incorporated into the item covering business continuity risks arising from natural disasters and other events.
- FY2025-H1RestatedAnnual report
「During the interim consolidated accounting period, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
It has been comprehensively confirmed that there have been no material changes regarding the risk of business suspension and delivery delays due to infectious diseases and other conditions. - FY2024-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no new business risks and no material changes in the business risks described in the annual securities report for the preceding fiscal year.」
It has been comprehensively confirmed that there have been no material changes regarding the risk of business suspension and delivery delays due to infectious diseases and other conditions. - FY2024-Q2RestatedAnnual report
「During the cumulative second-quarter period, there were no new business risks and no material changes in the business risks described in the annual securities report for the preceding fiscal year.」
It has been comprehensively confirmed that there have been no material changes regarding the risk of business suspension and delivery delays due to infectious diseases and other conditions. - FY2023First statedAnnual report
「If an infectious disease or other condition spreads at the Company's offices, it may cause human and property damage, business suspensions and delays, and a decline in orders. In addition, if an infectious disease or other condition spreads among the Company's customers, it may cause delays in delivery schedules and other impacts on customers.」
The disclosure describes the impact on operations of infectious disease outbreaks affecting the Company, its customers, suppliers and subcontractors.